Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1571550
PUBLISHER: Grand View Research | PRODUCT CODE: 1571550
Artificial Insemination Market Size, Share & Trends Analysis Report By Type (Intrauterine, Intracervical, Intravaginal, Intratubal), By Source Outlook, By End Use (AIH-Husband And AID-Donor), By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Artificial Insemination Market Growth & Trends:
The global artificial insemination market size is expected to reach USD 4.01 billion by 2030 registering a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.
Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).
Artificial Insemination Market Report Highlights:
- Intrauterine insemination (IUI) dominated the market with 71.7% of revenue share in 2023. This is due to its relatively simple procedure, minimal invasiveness, and effectiveness in treating various infertility issues.
- AIH-Husband dominated the market with 66.8% of revenue share in 2023. This is due to the increasing awareness and acceptance of assisted reproductive technologies among couples facing infertility challenges.
- Fertility clinics & others dominated the market with 53.2% share in 2023. These clinics offer a controlled environment with experienced medical professionals to perform the procedure, maximizing its effectiveness.
- Asia Pacific artificial insemination market dominated the market with 30.1% share in 2023. This growth is attributed to the rising number of infertile couples and technological advancements in the fertility segment.
Product Code: GVR-2-68038-176-4
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Artificial Insemination Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Artificial Insemination Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Artificial Insemination Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Artificial Insemination Market: Type Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Intrauterine Insemination
- 4.3.1. Intrauterine Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Intracervical Insemination
- 4.4.1. Intracervical Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Intravaginal Insemination
- 4.5.1. Intravaginal Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Intratubal Insemination
- 4.6.1. Intratubal Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Artificial Insemination Market: Source Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Artificial Insemination Market: Source Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. AIH-Husband
- 5.3.1. AIH-Husband Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. AID-Donor
- 5.4.1. AID-Donor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Artificial Insemination Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Artificial Insemination Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Fertility Clinics & Other Facilities
- 6.3.1. Fertility clinics & other facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Home
- 6.4.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Artificial Insemination Market: Regional Estimates & Trend Analysis
- 7.1. Artificial Insemination Market Share, By Region, 2023 & 2030, USD Million
- 7.2. North America
- 7.2.1. North America Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Canada Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Mexico Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
- 7.3.2.1. UK Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Germany Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. France Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Italy Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Spain Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Denmark Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Sweden Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Norway Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
- 7.4.2.1. China Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Japan Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. India Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. South Korea Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Australia Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Thailand Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Argentina Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. South Africa Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Saudi Arabia Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. UAE Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Kuwait Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. Vitrolife
- 8.4.1.1. Participant's Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Genea Pty Limited
- 8.4.2.1. Participant's Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Rinovum Women's Health, LLC
- 8.4.3.1. Participant's Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Pride Angel
- 8.4.4.1. Participant's Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. HI-TECH SOLUTIONS
- 8.4.5.1. Participant's Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. FUJIFILM Irvine Scientific
- 8.4.6.1. Participant's Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Kitazato Corporation
- 8.4.7.1. Participant's Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Rocket Medical plc
- 8.4.8.1. Participant's Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Conceivex, Inc.
- 8.4.9.1. Participant's Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.1. Vitrolife
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.